Goodness Growth Holdings Announces Third Quarter 2023 Results

Q3 revenue of $24.7 million increased 44.0% YoY and 28.2% sequentially excluding discontinued operations –

– Stronger revenue growth and margins largely driven by adult-use activation in Maryland –

– Record operating income reflects Maryland's performance and early returns on our strategic plan, despite continued headwinds in New York –

– New York divestiture process taking longer than anticipated –

MINNEAPOLIS, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS; OTCQX: GDNSF), a cannabis company committed to providing safe access, quality products and great value to its customers, today reported financial results for its third quarter ended September 30, 2023. Key financial results are presented below in summary form with supporting commentary and discussion from management of certain key operating metrics which the Company uses to judge its performance. All currency figures referenced herein are denominated in U.S. dollars.

Summary of Key Financial Metrics Three Months Ended Nine Months Ended
US $ in millions September 30, September 30,
2023 2022 Variance 2023 2022 Variance
GAAP Revenue $24.7 $18.9 30.9% $64.0 $55.6 15.1%
Revenue (excluding discontinued operations) $24.7 $17.1 44.0% $62.0 $48.2 28.4%
GAAP Gross Profit $13.2 $9.5 38.4% $32.0 $22.4 43.1%
Gross Profit Margin 53.5% 50.6% 290 bps 50.1% 40.3% 980 bps
SG&A Expenses $6.7 $8.5 -20.5% $22.0 $26.4 -16.8%
SG&A Expenses (% of Sales) 27.4% 45.0% 1,760 bps 34.3% 47.5% 1,320 bps
Operating Income (Loss) $5.9 ($0.2) NM $5.2 ($7.6) NM
Operating Income Margin 23.8% (1.0%) 2,480 bps 8.1% -13.7% 2,180 bps
EBITDA $7.0 ($1.2) NM $11.3 ($10.8) NM
EBITDA Margin 28.5% (6.5%) 3,500 bps 17.7% (19.4%) 3,710 bps
NM = Not Meaningful

Management Commentary

Interim Chief Executive Officer Josh Rosen commented, "The strength of our third quarter results reflects a combination of benefits from our recent operational improvement initiatives and regulatory catalysts in Maryland following the launch of adult use sales in July. We are very proud of our team, who have adapted quickly to our decentralized approach to operations. These efforts and the substantial regulatory catalyst in Maryland enabled us to produce positive cash flow from operations in the quarter. De-risking our balance sheet remains a critical focus, and while we have not yet executed definitive documents related to our divestiture process in New York, we expect to do so before the end of this year and look forward to sharing more visibility into our future profitability expectations once that process is complete."

Amber Shimpa, President and CEO of Vireo Health of Minnesota commented, "Our operational key performance indicators continued to improve during the quarter despite the seasonal challenges we experience in our greenhouse environment in Minnesota. We are encouraged by the strength of our performance in the Maryland market following the implementation of adult-use. Based on early indications, we believe we are outpacing the overall market growth in Maryland, which is an internal goal and standard by which we measure our performance. In Minnesota, we remain focused on driving better value and quality of products for patients as we move out of what is seasonally a very challenging climate for our flower production."

Core Market KPIs 1 Three Months Ended Nine Months Ended
US $ in millions September 30, September 30,
2023 2022 Variance 2023 2022 Variance
Total Harvest Pounds (Biomass) 9,111 7,530 21.0% 27,142 20,727 30.9%
% "A" Flower 2 20.5 % 18.7 % 180 bps 19.5 % 16.9 % 260 bps
Total Retail Revenue $20.1 $14.7 37.4% $51.8 $40.9 26.8%
Same Store Sales Growth - - 37.4% - - 26.8%
Minnesota - - 15.0 % - - 26.6 %
New York - - -14.0% - - -16.7%
Maryland - - 229.4 % - - 88.7 %
Total Wholesale Revenue $4.5 $2.5 83.7% $9.9 $7.4 34.5%
1 Core Markets refer to the Company's operations in Maryland, Minnesota, and New York.
2 "A Flower" refers to produced biomass that meet the Company's highest internal standards for flower quality, size, and appearance.

Other Events

On August 14, 2023, the Company announced that it has entered into consulting, licensing and wholesale agreements with two additional dispensaries in Maryland that are owned and controlled by HA-MD LLC and currently operate under the Ethos brand name. The agreements will result in the two Ethos dispensaries in Hampden and Rockville being, upon regulatory approval, rebranded to Green Goods® and include an option to acquire the two dispensaries if and when allowed by applicable law and regulations.

On October 5, 2023, the Company announced that it completed previously disclosed warrant issuances with Grown Rogue International, Inc. Goodness Growth issued 10,000,000 warrants to purchase subordinate voting shares of Goodness Growth to Grown Rogue, with a strike price equal to C$0.317 (US$0.233), which represented a 25.0 percent premium to the 10-day volume weighted average price ("VWAP") of Goodness Growth's subordinate voting shares on the trading day immediately prior to the effective date of the Agreement. Similarly, Grown Rogue issued 8,500,000 warrants to purchase shares of Grown Rogue to Goodness Growth, with a strike price equal to C$0.225 (US$0.166), which represented a 25.0 percent premium to the 10-day VWAP of Grown Rogue's subordinate voting shares on the trading day immediately prior to the effective date of the Agreement. The warrants exchanged in the agreement were issued with five-year terms to exercise.

On October 30, 2023, the Company announced that it executed a fifth amendment to its lease with its landlord on its cannabis cultivation and manufacturing facilities located in Johnstown, New York. The Company and its landlord agreed to increase the tenant improvement allowance on the lease by an additional $14.0 million, with the increase in funds to be utilized to support the completion of the construction of the Company's indoor expansion project which was announced in September 2021. The parties also agreed to a monthly base rental increase of $210,000 beginning November 2023. Goodness Growth management stated that the amendment is intended to support the Company's ongoing divestment process in the State of New York.

Balance Sheet and Liquidity

As of September 30, 2023, total current assets were $135.1 million, including cash on hand of $13.3 million. Total current liabilities were $165.4 million.

As of September 30, 2023, including the required issuance of warrants to Grown Rogue International, Inc., the Company had a total of 143,126,330 equity shares issued and outstanding on an as-converted basis, 236,986,611 shares outstanding on an as-converted, fully diluted basis, and 153,573,359 fully-diluted shares outstanding on the treasury method basis.

Conference Call and Webcast Information

Goodness Growth management will host a conference call with research analysts today, November 14, 2023, at 5:00 p.m. ET (4:00 p.m. CT) to discuss its financial results for its third quarter ended September 30, 2023. Interested parties may attend the conference call by dialing 1-888-414-4585 (Toll-Free) (US and Canada) or 1-646-960-0331 (Toll) (International) and referencing conference ID number 8663261.

A live audio webcast of this event will also be available in the Events & Presentations section of the Company's Investor Relations website and via the following link:
https://events.q4inc.com/attendee/917057239 .

About Goodness Growth Holdings, Inc.

Goodness Growth Holdings, Inc. is a cannabis company whose mission is to provide safe access, quality products and value to its customers while supporting its local communities through active participation and restorative justice programs. The Company is evolving with the industry and is in the midst of a transformation to being significantly more customer-centric across its operations, which include cultivation, manufacturing, wholesale and retail business lines. Today, the Company is licensed to grow, process, and/or distribute cannabis in four markets and operates 14 dispensaries in three states. For more information about Goodness Growth Holdings, please visit www.goodnessgrowth.com .

Additional Information

Additional information relating to the Company's third quarter 2023 results will be available on EDGAR and SEDAR later today. Goodness Growth refers to certain non-GAAP financial measures such as Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) in circumstances in which the Company believes that doing so provides additional perspective and insights when analyzing the core operating performance of the business. These measures do not have any standardized meaning and may not be comparable to similar measures presented by other issuers. Please see the Supplemental Information and Reconciliation of Non-GAAP Financial Measures at the end of this news release for more detailed information regarding non-GAAP financial measures.

Contact Information

Investor Inquiries:
Sam Gibbons
Managing Director
sam.gibbons@alpha-ir.com
(612) 314-8995
Media Inquiries:
Amanda Hutcheson
Senior Manager, Communications
amandahutcheson@goodnessgrowth.com
(919) 815-1476

Forward-Looking Statement Disclosure

This press release contains "forward-looking information" within the meaning of applicable United States and Canadian securities legislation. To the extent any forward-looking information in this press release constitutes "financial outlooks" within the meaning of applicable United States or Canadian securities laws, this information is being provided as preliminary financial results; the reader is cautioned that this information may not be appropriate for any other purpose and the reader should not place undue reliance on such financial outlooks. Forward-looking information contained in this press release may be identified by the use of words such as "should," "believe," "estimate," "would," "looking forward," "may," "continue," "expect," "expected," "will," "likely," "intend," "subject to," "transformation," and "pending," variations of such words and phrases, or any statements or clauses containing verbs in any future tense. These statements should not be read as guarantees of future performance or results. Forward-looking information includes both known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the Company or its subsidiaries to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements or information contained in this press release. Financial outlooks, as with forward-looking information generally, are, without limitation, based on the assumptions and subject to various risks as set out herein and in our Annual Report on Form 10-K filed with the Securities Exchange Commission. Our actual financial position and results of operations may differ materially from management's current expectations and, as a result, our revenue, EBITDA, and cash on hand may differ materially from the values provided in this press release. Forward-looking information is based upon a number of estimates and assumptions of management, believed but not certain to be reasonable, in light of management's experience and perception of trends, current conditions, and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment, and the availability of licenses, approvals and permits.

Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, the reader should not place undue reliance on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to: risks related to the timing and content of adult-use legislation in markets where the Company currently operates; current and future market conditions, including the market price of the subordinate voting shares of the Company; risks related to epidemics and pandemics; federal, state, local, and foreign government laws, rules, and regulations, including federal and state laws and regulations in the United States relating to cannabis operations in the United States and any changes to such laws or regulations; operational, regulatory and other risks; execution of business strategy; management of growth; difficulties inherent in forecasting future events; conflicts of interest; risks inherent in an agricultural business; risks inherent in a manufacturing business; liquidity and the ability of the Company to raise additional financing to continue as a going concern; the Company's ability to meet the demand for flower in Minnesota; risk of failure in the lawsuit with Verano and the cost of that litigation; our ability to dispose of our assets held for sale at an acceptable price or at all; and risk factors set out in the Company's Annual Report on Form 10-K for the year ended December 31, 2022, which is available on EDGAR with the U.S. Securities and Exchange Commission and filed with the Canadian securities regulators and available under the Company's profile on SEDAR at www.sedar.com .

The statements in this press release are made as of the date of this release. Except as required by law, we undertake no obligation to update any forward-looking statements or forward-looking information to reflect events or circumstances after the date of such statements.

Supplemental Information

The financial information reported in this news release is based on unaudited financial statements for the fiscal quarters ended September 30, 2023, and September 30, 2022. All financial information contained in this news release is qualified in its entirety with reference to such financial statements. To the extent that the financial information contained in this news release is inconsistent with the information contained in the Company's audited financial statements, the financial information contained in this news release shall be deemed to be modified or superseded by the Company's audited financial statements. The making of a modifying or superseding statement shall not be deemed an admission for any purposes that the modified or superseded statement, when made, constituted a misrepresentation for purposes of applicable securities laws.

GOODNESS GROWTH HOLDINGS, INC.
CONSOLIDATED BALANCE SHEETS AS OF 9/30/2023 AND 12/31/2022
(Amounts Expressed in United States Dollars, Unaudited and Condensed)
September 30, December 31,
2023
2022
Assets
Current assets:
Cash $ 13,296,137 $ 15,149,333
Accounts receivable, net of allowance for doubtful accounts of $344,937 and $453,860, respectively 5,688,782 4,286,072
Inventory 19,056,338 20,508,023
Prepayments and other current assets 1,834,013 2,544,532
Notes receivable, current 3,750,000
Warrants Receivable 1,566,445
Assets Held for Sale 89,918,392 4,240,781
Total current assets 135,110,107 46,728,741
Property and equipment, net 23,812,949 89,606,932
Operating lease, right-of-use asset 2,182,174 6,110,787
Notes receivable, long-term 3,750,000
Intangible assets, net 8,935,019 8,776,946
Goodwill 183,836
Deposits 383,645 2,312,161
Deferred tax assets 1,245,000 1,687,000
Total assets $ 171,668,894 $ 159,156,403
Liabilities
Current liabilities
Accounts Payable and Accrued liabilities $ 33,638,534 $ 14,928,780
Long-Term debt, current portion 55,432,463 11,780,000
Right of use liability 907,998 1,680,294
Liabilities held for sale 75,439,119 1,319,847
Total current liabilities 165,418,114 29,708,921
Right-of-use liability 9,700,492 79,757,994
Other long-term liabilities 235,577
Convertible debt, net 5,107,477
Long-Term debt 4,060,633 46,248,604
Total liabilities $ 184,522,293 $ 155,715,519
Stockholders' equity
Subordinate Voting Shares ($- par value, unlimited shares authorized; 108,332,330 shares issued and outstanding)
Multiple Voting Shares ($- par value, unlimited shares authorized; 347,940 shares issued and outstanding)
Super Voting Shares ($- par value; unlimited shares authorized; 0 shares issued and outstanding)
Additional Paid in Capital 185,991,816 181,321,847
Accumulated deficit (198,845,215 ) (177,880,963 )
Total stockholders' equity $ (12,853,399 ) $ 3,440,884
Total liabilities and stockholders' equity $ 171,668,894 $ 159,156,403


GOODNESS GROWTH HOLDINGS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022
(Amounts Expressed in United States Dollars, Unaudited and Condensed)
Three Months Ended Nine Months Ended
September 30, September 30,
2023
2022
2023
2022
Revenue $ 24,675,145 $ 18,854,101 $ 63,960,125 $ 55,582,821
Cost of sales
Product costs 10,493,561 9,186,241 30,347,357 29,532,469
Inventory valuation adjustments 984,196 131,000 1,563,872 3,657,788
Gross profit 13,197,388 9,536,860 32,048,896 22,392,564
Operating expenses:
Selling, general and administrative 6,749,314 8,489,728 21,965,576 26,393,136
Stock-based compensation expenses 296,617 896,081 4,009,415 2,636,594
Depreciation 99,929 167,940 377,121 487,164
Amortization 180,034 172,267 498,828 516,800
Total operating expenses 7,325,894 9,726,016 26,850,940 30,033,694
Gain (loss) from operations 5,871,494 (189,156 ) 5,197,956 (7,641,130 )
Other income (expense):
Impairment of long-lived assets (2,108,703 ) (7,476,618 )
Gain (loss) on disposal of assets (50,686 ) (2,798,567 ) 168,359
Gain (loss) on sale of property and equipment 7,583 (3,347 )
Interest expenses, net (7,915,658 ) (5,573,263 ) (22,795,242 ) (15,472,885 )
Other income (expenses) 345,824 79,750 6,166,472 1,196,975
Other income (expenses), net (7,620,520 ) (7,594,633 ) (19,427,337 ) (21,587,516 )
Loss before income taxes (1,749,026 ) (7,783,789 ) (14,229,381 ) (29,228,646 )
Current income tax expenses (3,980,000 ) (1,790,000 ) (7,357,871 ) (4,130,000 )
Deferred income tax recoveries 500,000 1,150,000 623,000 4,185,000
Net loss and comprehensive loss (5,229,026 ) (8,423,789 ) (20,964,252 ) (29,173,646 )
Net loss per share - basic and diluted $ (0.04 ) $ (0.07 ) $ (0.16 ) $ (0.23 )
Weighted average shares used in computation of net loss per share - basic & diluted 141,332,852 128,120,949 132,576,879 128,114,570


GOODNESS GROWTH HOLDINGS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022
(Amounts Expressed in United States Dollars, Unaudited and Condensed)
September 30,
2023
2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss $ (20,964,252 ) $ (29,173,646 )
Adjustments to reconcile net loss to net cash used in operating activities:
Inventory valuation adjustments 1,563,872 3,657,788
Depreciation 377,121 487,164
Depreciation capitalized into inventory 1,846,418 1,959,536
Non-cash operating lease expense 423,821 852,687
Amortization of intangible assets 498,828 516,800
Amortization of intangible assets capitalized into inventory 24,779
Stock-based payments 4,009,415 2,636,594
Warrants receivable (1,566,445 )
Interest Expense 5,111,930 3,430,733
Impairment of long-lived assets 7,476,618
Deferred income tax (623,000 ) (4,185,000 )
Accretion 800,392 3,407,030
Loss (gain) on sale of property and equipment 3,347
Loss on disposal of Red Barn Growers 2,909,757
Loss (gain) on disposal of assets (111,190 )
Gain on disposal of royalty asset (168,359 )
Change in operating assets and liabilities:
Accounts Receivable (902,709 ) (1,408,580 )
Prepaid expenses 684,987 (1,601,742 )
Inventory (1,932,554 ) (2,205,236 )
Accounts payable and accrued liabilities 7,459,350 2,360,044
Change in assets and liabilities held for sale (116,882 )
Net cash used in operating activities $ (506,362 ) $ (11,954,222 )
CASH FLOWS FROM INVESTING ACTIVITIES:
PP&E Additions $ (2,630,724 ) $ (4,938,587 )
Intangible license additions (1,090,919 )
Proceeds from sale of Red Barn Growers net of cash 439,186 387,512
Proceeds from sale of property, plant, and equipment 242,088
Proceeds from sale of royalty asset 236,635
Deposits (263,545 ) (482,539 )
Net cash provided by (used in) investing activities $ (3,303,914 ) $ (4,796,979 )
CASH FLOWS FROM FINANCING ACTIVITIES $ $
Proceeds from long-term debt, net of issuance costs 24,868,143
Proceeds from convertible debt, net of issuance costs 5,348,140
Proceeds from option exercises 7,201
Debt principal payments (1,976,362 )
Lease principal payments (1,414,698 ) (1,437,346 )
Net cash provided by (used in) financing activities $ 1,957,080 $ 23,437,998
Net change in cash $ (1,853,196 ) $ 6,686,797
Cash, beginning of period $ 15,149,333 $ 15,155,279
Cash, end of period $ 13,296,137 $ 21,842,076


GOODNESS GROWTH HOLDINGS, INC.
STATE-BY-STATE REVENUE PERFORMANCE
THREE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022
Three Months Ended
September 30,
2023
2022
$ Change % Change
Retail:
MN $ 11,791,001 $ 10,252,523 $ 1,538,478 15 %
NY 2,185,701 2,541,913 (356,212 ) (14 ) %
NM 1,721,017 (1,721,017 ) (100 ) %
MD 6,170,372 1,873,773 4,296,599 229 %
Total Retail $ 20,147,074 $ 16,389,226 $ 3,757,848 23 %
Wholesale:
MD 2,923,376 1,333,864 1,589,512 119 %
NY 1,375,730 1,131,011 244,719 22 %
NM 100 %
Total Wholesale $ 4,299,106 $ 2,464,875 $ 1,834,231 74 %
MD Service Revenue 228,965 228,965 100 %
Total Revenue $ 24,675,145 $ 18,854,101 $ 5,821,044 31 %
AZ and NM Revenue $ $ (1,721,017 ) $ 1,721,017 (100 ) %
Total Revenue excluding AZ and NM $ 24,675,145 $ 17,133,084 $ 7,542,061 44 %


GOODNESS GROWTH HOLDINGS, INC.
STATE-BY-STATE REVENUE PERFORMANCE
NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022
Nine Months Ended
September 30,
2023
2022
$ Change % Change
Retail:
MN $ 33,989,289 $ 26,844,812 $ 7,144,477 27 %
NY 6,827,278 8,193,540 (1,366,262 ) (17 ) %
NM 1,964,285 4,984,945 (3,020,660 ) (61 ) %
MD 10,981,121 5,819,644 5,161,477 89 %
Total Retail $ 53,761,973 $ 45,842,941 $ 7,919,032 17 %
Wholesale:
AZ $ $ 2,355,683 $ (2,355,683 ) (100 ) %
MD 6,324,396 4,162,287 2,162,109 52 %
NY 3,605,064 2,549,770 1,055,294 41 %
NM 39,727 39,727 100 %
MN 672,140 (672,140 ) (100 ) %
Total Wholesale $ 9,969,187 $ 9,739,880 $ 229,307 2 %
MD Service Revenue 228,965 - 228,965 100 %
Total Revenue $ 63,960,125 $ 55,582,821 $ 8,377,304 15 %
AZ and NM Revenue $ (2,004,012 ) $ (7,340,628 ) $ 5,336,616 (73 ) %
Total Revenue excluding AZ and NM $ 61,956,113 $ 48,242,193 $ 13,713,920 28 %

Reconciliation of Non-GAAP Financial Measures

Goodness Growth management occasionally elects to provide certain non-GAAP financial measures such as Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA). EBITDA is a non-GAAP measure and does not have a standardized definition under GAAP. The following information provides reconciliations of the supplemental non-GAAP financial measures, presented herein to the most directly comparable financial measures calculated and presented in accordance with GAAP. The Company has provided the non-GAAP financial measures, which are not calculated or presented in accordance with GAAP, as supplemental information and in addition to the financial measures that are calculated and presented in accordance with GAAP. These supplemental non-GAAP financial measures should not be considered superior to, as a substitute for or as an alternative to, and should be considered in conjunction with, the GAAP financial measures presented.

Reconciliation of Net Loss to EBITDA
Three Months Ended Nine Months Ended
September 30, September 30,
2023
2022
2023
2022
Net income (loss) $ (5,229,026 ) $ (8,423,789 ) (20,964,252 ) (29,173,646 )
Interest expense, net 7,915,658 5,573,263 22,795,242 15,472,885
Income taxes 3,480,000 640,000 6,734,871 (55,000 )
Depreciation & Amortization 279,963 340,207 875,949 1,003,964
Depreciation included in cost of goods sold 577,132 645,480 1,871,197 1,959,536
EBITDA (non-GAAP) $ 7,023,727 $ (1,224,839 ) 11,313,007 (10,792,261 )


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

CNX:GDNS,GDNSF
The Conversation (0)

Cronos Group Inc. enters into agreement for the sale-leaseback of its Stayner, Ontario facility

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company") today announced that its wholly owned subsidiary entered into an agreement (the "Sale Agreement") with Future Farmco Canada Inc. (the "Buyer"), a vertical farming company, for the sale and leaseback of its property located at 4491 Concession 12 Sunnidale Road, Stayner, Ontario, Canada, L0M 1S0 (the "Peace Naturals Campus"). Pursuant to the terms of the Sale Agreement, the Buyer has agreed to acquire the Peace Naturals Campus for C$23 million cash, subject to the terms and conditions set forth therein. The parties also plan to enter into a lease agreement upon closing for portions of the Peace Naturals Campus, ensuring continued operations.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
cannabis leaves, statue of liberty

Cannabis Weekly Round-Up: New York Aims to Ease Banking Barriers, Wisconsin Issues Pardons

Cannabis businesses in New York are set to receive easier access to banking services.

Meanwhile, Wisconsin's governor was in a giving mood this week — ahead of the Thanksgiving holiday, he granted pardons to dozens of people with with cannabis-related convictions.

Read on to learn what else happened in the cannabis space this week.

Keep reading...Show less
Emyria Limited

Eminent Healthcare Leader Appointed as Independent Non-Executive Chairman for Emyria Ltd

Emyria Limited (ASX: EMD) (“Emyria”, or the “Company”) focused on developing innovative treatments for mental health and neurological conditions, is pleased to announce the appointment of Greg Hutchinson as Independent Non-Executive Chairman.

Keep reading...Show less
Melodiol Global Health Limited

Capital Raising Re-Price & Prospectus Offers Extension

Melodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’) provides an update to its previously announced capital raise and debt conversions (refer to ASX announcement dated 26 October 2023). In an effort to accelerate the receipt of funds, the Company has re-priced the issue price per fully paid ordinary share ('Shares’) for the capital raise from $0.005 to $0.002904. Under the new issue price, the Company advises that it has received firm commitments to raise approximately $1m (before costs) through the issue of approximately 348,108,292 new Shares (the ‘Revised Placement’). Additionally, the Company has also re-negotiated and agreed with creditors to convert $284,454 of amounts outstanding to equity, via the issuance of 108,743,113 Shares at an issue price of $0.002904 per Share (instead of $0.005 per Share), being on the same terms as the Revised Placement (‘Revised Debt Conversions').

Keep reading...Show less
ohio flag with gavel

Cannabis Weekly Round-Up: Ohio Legalizes Adult-use Cannabis, Aurora and Canopy Release Results

Ohio has officially become the latest US state to allow recreational cannabis for adult users.

Meanwhile, a survey conducted by a leading financial research firm suggests that investors feel optimistic that cannabis will be rescheduled in the US. And in Canada, quarterly results show two cannabis producers are seeing some relief.

Read on to learn what else happened in the cannabis space this week.

Keep reading...Show less

Trulieve Reports Third Quarter 2023 Results Delivering Significant Cash Generation

  • Generated cash flow from operations of $93 million and free cash flow of $87 million
  • Reduced debt with purchase of $57 million of 2026 notes and announced redemption of $130 million of 2024 notes, resulting in $20 million in interest savings through maturity
  • Expect 2023 operating cash flow of at least $100 million and free cash flow of at least $70 million

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced its results for the quarter ended September 30, 2023 . Results are reported in U.S. dollars and in accordance with U.S. Generally Accepted Accounting Principles unless otherwise indicated. Numbers may not sum perfectly due to rounding.

Trulieve logo (PRNewsfoto/Trulieve Cannabis Corp.)

Q3 2023 Financial and Operational Highlights*

  • Revenue of $275 million , with 96% of revenue from retail sales.
  • Achieved GAAP gross margin of 52%, with gross profit of $143 million .
  • SG&A expenses lowered by $2 million sequentially to $94 million .
  • Reported net loss of $25 million . Adjusted net loss of $15 million * excludes non-recurring charges, disposals and discontinued operations.
  • Achieved EBITDA of $74 million *, or 27% of revenue and adjusted EBITDA of $78 million *, or 28% of revenue.
  • Purchased $57 million face value senior secured 2026 notes for USD $47.6 million in September, which represents a 16.5% discount to par, plus accrued interest.
  • Cash as of September 30, 2023 of approximately $200 million .
  • Generated cash flow from operations of $93 million and free cash flow of $87 million in the third quarter. Anticipate 2023 cash flow from operations of at least $100 million and free cash flow generation of at least $70 million .
  • Realized 235% increase in Maryland traffic in Q3 compared to Q2 following the launch of adult-use sales at our three dispensaries.
  • Opened five new dispensaries in Pace and Sanford, FL , Evans and Pooler, GA , and Columbus, OH and relocated one dispensary in Kissimmee, FL.
  • Ended the quarter with 32% of retail locations outside of the state of Florida .

*See "Non-GAAP Financial Measures" below for additional information and a reconciliation to GAAP for all Non-GAAP metrics.

Recent Developments

  • Announced redemption of $130 million of senior secured notes due June 18, 2024 with redemption date of December 1, 2023 .
  • Filed amended federal tax returns for 2019, 2020, and 2021 claiming a $143 million refund from taxes paid.
  • On November 8, 2023 , the Florida Supreme Court heard oral arguments regarding the Smart and Safe Florida ballot initiative for adult use. The court is expected to rule prior to April 2024 .
  • Launched distribution through independent pharmacies in Georgia .
  • Added retail locations in Apollo Beach and Marianna, FL and relocated one dispensary in Melbourne, FL.
  • Currently operate 190 retail dispensaries and over 4 million square feet of cultivation and processing capacity in the United States .

Management Commentary
"This year our team has done a phenomenal job executing on our plan to generate cash while making investments to support future growth," said Kim Rivers , Trulieve CEO. "As demonstrated this quarter, Trulieve remains aligned with our shareholders, and is committed to strengthening our balance sheet with non-dilutive measures. With significant scale and service, strong cash generation, and a clearly defined strategy, Trulieve is best positioned for the coming wave of meaningful growth catalysts."

Financial Highlights*

Results of Operations

For the Three Months Ended

For the Nine Months Ended


(Figures in millions except
per share data and %
change based on these
figures)

September
30, 2023

September
30, 2022

change

June 30,
2023

change

September
30, 2023

September
30, 2022

change


Revenue

$

275

$

295

(7 %)

$

282

(2 %)

$

842

$

920

(8 %)


Gross Profit

$

143

$

169

(15 %)

$

142

1 %

$

435

$

532

(18 %)


Gross Margin %


52 %


57 %



50 %



52 %


58 %



Operating Expenses

$

120

$

196

(39 %)

$

433

(72 %)

$

686

$

487

41 %


Operating Expenses %


43 %


66 %



154 %



81 %


53 %



Net Loss**

$

(25)

$

(115)

---

$

(404)

---

$

(493)

$

(169)

---


Net Loss Continuing Ops

$

(23)

$

(73)

---

$

(342)

---

$

(399)

$

(118)

---


Adjusted Net Income (Loss)

$

(15)

$

8

---

$

(15)

---

$

(47)

$

15

---


Diluted Shares Outstanding


189


189



189



189


188



EPS Continuing Ops

$

(0.12)

$

(0.38)

---

$

(1.80)

---

$

(2.09)

$

(0.63)

---


Adjusted EPS

$

(0.08)

$

0.04

---

$

(0.08)

---

$

(0.25)

$

0.08

---


Adjusted EBITDA

$

78

$

100

(22 %)

$

79

(1 %)

$

235

$

316

(26 %)


Adjusted EBITDA Margin %


28 %


34 %



28 %



28 %


34 %




*See "Non-GAAP Financial Measures" below for additional information and a reconciliation to GAAP for all Non-GAAP metrics.

**Net loss and comprehensive loss attributable to common shareholders which Includes discontinued operations and excludes non-controlling interest.

Conference Call
The Company will host a conference call and live audio webcast on November 9, 2023 , at 8:30 A. M . Eastern time, to discuss its third quarter 2023 financial results. Interested parties can join the conference call by dialing in as directed below. Please dial in 15 minutes prior to the call.

North American toll free: 1-888-317-6003


Passcode: 8045472

International: 1-412-317-6061


Passcode: 8045472

A live audio webcast of the conference call will be available at:
https://app.webinar.net/RXq1eDnkyL2

A powerpoint presentation and archived replay of the webcast will be available at:
https://investors.trulieve.com/events  

The Company's Form 10-Q for the quarter ended September 30, 2023 , will be available on the SEC's website or at https://investors.trulieve.com/quarterly-results . The Company's Management Discussion and Analysis for the period and the accompanying financial statements and notes will be available under the Company's profile on SEDAR and on its website at https://investors.trulieve.com/quarterly-results . This news release is not in any way a substitute for reading those financial statements, including the notes to the financial statements.

Trulieve Cannabis Corp.

Condensed Consolidated Balance Sheets (Unaudited)

(in millions, expect per share data)



September 30,
2023


December 31,
2022




(Audited)

ASSETS




Current Assets:




Cash and cash equivalents

$                 192.2


$              207.2

Restricted cash

6.7


6.6

Accounts receivable, net

6.9


6.5

Inventories

229.9


276.5

Prepaid expenses and other current assets

43.7


62.3

Notes receivable - current portion

1.1


0.7

Assets associated with discontinued operations

6.2


33.7

Total current assets

486.7


593.5

Property and equipment, net

687.6


743.3

Right of use assets - operating, net

96.3


98.9

Right of use assets - finance, net

61.1


70.5

Intangible assets, net

934.6


984.8

Goodwill

483.9


791.5

Notes receivable, net

12.0


12.0

Other assets

11.1


12.8

Long-term assets associated with discontinued operations

2.0


93.1

TOTAL ASSETS

$              2,775.2


$           3,400.4

LIABILITIES




Current Liabilities:




Accounts payable and accrued liabilities

$                   86.4


$                82.0

Income tax payable


49.6

Deferred revenue

3.6


9.5

Notes payable - current portion

9.1


12.5

Private placement notes - current portion, net

126.9


Operating lease liabilities - current portion

9.7


10.3

Finance lease liabilities - current portion

7.5


8.3

Construction finance liabilities - current portion

1.4


1.2

Contingencies

3.8


34.7

Liabilities associated with discontinued operations

3.3


2.3

Total current liabilities

$                 251.8


$              210.3

Long-term liabilities:




Notes payable, net

92.3


94.2

Private placement notes, net

362.8


541.7

Operating lease liabilities

92.6


99.9

Finance lease liabilities

63.6


69.9

Construction finance liabilities

136.8


137.1

Deferred tax liabilities

205.4


224.9

Other long-term liabilities

86.4


26.3

Long-term liabilities associated with discontinued operations

42.6


68.4

TOTAL LIABILITIES

$              1,334.5


$           1,472.7

SHAREHOLDERS' EQUITY




Common stock, no par value; unlimited shares authorized. 185,987,512 and issued
and outstanding as of September 30, 2023 and December 31, 2022, respectively.

$                       —


$                    —

Additional paid-in-capital

2,052.4


2,045.0

Accumulated deficit

(607.2)


(113.8)

Non-controlling interest

(4.5)


(3.5)

TOTAL SHAREHOLDERS' EQUITY

1,440.7


1,927.7

TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

$              2,775.2


$           3,400.4

Trulieve Cannabis Corp.

Condensed Consolidated Statements of Operations (Unaudited)

(in millions, except per share data)



Three Months Ended


Nine Months Ended


September
30, 2023


September
30, 2022


September
30, 2023


September
30, 2022

Revenue

$            275.2


$            295.4


$            842.2


919.8

Cost of goods sold

132.3


126.6


407.4


387.7

Gross profit

142.9


168.7


434.8


532.0

Expenses:








Sales and marketing

59.4


74.3


181.2


219.7

General and administrative

34.5


37.6


108.7


104.6

Depreciation and amortization

27.0


29.5


82.6


86.6

Impairments and disposals of long-lived assets, net

(1.2)


54.6


5.5


76.2

Impairment of goodwill



307.6


Total expenses

119.6


196.1


685.6


487.1

Income (loss) from operations

23.3


(27.3)


(250.8)


44.9

Other (expense) income:








Interest expense, net

(20.8)


(17.7)


(60.9)


(52.2)

Change in fair value of derivative liabilities - warrants


0.4


0.3


2.6

Other income, net

11.2


0.4


18.1


3.0

Total other expense, net

(9.6)


(16.9)


(42.6)


(46.6)

Income (loss) before provision for income taxes

13.7


(44.3)


(293.4)


(1.7)

Provision for income taxes

36.6


28.4


105.9


116.8

Net loss from continuing operations

(22.9)


(72.6)


(399.3)


(118.4)

Net loss from discontinued operations, net of tax
(provision) benefit of $5, $13,152, $(625), and
$14,467 respectively

(2.9)


(42.4)


(99.1)


(53.2)

Net loss

(25.8)


(115.1)


(498.3)


(171.6)

Less: Net loss attributable to non-controlling interest
from continuing operations

(0.5)


(0.5)


(3.8)


(2.6)

Less: Net loss attributable to non-controlling interest
from discontinued operations



(1.2)


Net loss attributable to common shareholders

$            (25.4)


$          (114.6)


$          (493.4)


$          (169.0)

Net loss per share - Continuing operations:








Basic and diluted

$            (0.12)


$            (0.38)


$            (2.09)


$            (0.63)

Net loss per share - Discontinued operations:








Basic and diluted

$            (0.02)


$            (0.23)


$            (0.52)


$            (0.28)

Weighted average number of common shares used in
computing net loss per share:








Basic and diluted

188.9


188.6


189.0


187.5

Non-GAAP Financial Measures
In addition to our results determined in accordance with GAAP, we supplement our results with non-GAAP financial measures, including adjusted EBITDA, adjusted net loss (income), adjusted net income (loss) per diluted share and free cash flow. Our management uses these non-GAAP financial measures in conjunction with GAAP financial measures to evaluate our operating results and financial performance. We believe these measures are useful to investors as they are widely used measures of performance and can facilitate comparison to other companies. These non-GAAP financial measures are not, and should not be considered as, measures of liquidity. These non-GAAP financial measures have limitations as analytical tools in that they do not reflect all of the amounts associated with our results of operations as determined in accordance with GAAP. Because of these limitations, these non-GAAP financial measures should be considered along with GAAP financial performance measures. The presentation of these non-GAAP financial measures is not intended to be considered in isolation or as a substitute for, or superior to, financial information prepared and presented in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures. A reconciliation of the non-GAAP financial measures to such GAAP measures can be found below. These non-GAAP financial measures should be considered supplemental to, and not a substitute for, our reported financial results prepared in accordance with GAAP.

Reconciliation of Non-GAAP Adjusted EBITDA
The following table presents a reconciliation of GAAP net loss to non-GAAP Adjusted EBITDA, for each of the periods presented:

(Amounts expressed in millions of United States
dollars)

Three Months Ended

Nine Months Ended

September 30,
2023

September 30,
2022

June 30,
2023

September 30,
2023

September 30,
2022

Net Loss GAAP

$

(25.4)

$

(114.6)

$

(403.8)

$

(493.4)

$

(169.0)

Add (Deduct) Impact of:











Interest Expense

$

20.8

$

17.7

$

18.9

$

60.9

$

52.2

Provision For Income Taxes

$

36.6

$

28.4

$

34.0

$

105.9

$

116.8

Depreciation and Amortization

$

27.0

$

29.5

$

26.1

$

82.6

$

86.6

Depreciation in COGS

$

14.6

$

13.2

$

16.0

$

42.8

$

34.9

EBITDA

$

73.7

$

(25.8)

$

(308.9)

$

(201.1)

$

121.5












Impairment of Goodwill

$

$

$

307.6

$

307.6

$

Impairments and Disposals of Long-lived
Assets, Net

$

(1.2)

$

54.6

$

3.3

$

5.5

$

76.2

Results of Discontinued Operations

$

2.9

$

42.4

$

63.9

$

97.9

$

53.2

Acquisition and Transaction Costs

$

$

7.0

$

$

$

17.2

Integration and Transition Costs

$

8.5

$

6.7

$

5.7

$

16.1

$

17.1

Other Non-Recurring Costs

$

$

1.9

$

$

$

11.6

Share-Based Compensation

$

4.5

$

4.3

$

0.5

$

7.4

$

14.6

Legislative Campaign Contributions

$

0.5

$

10.0

$

8.6

$

19.6

$

10.0

Inventory Step Up Fair Value

$

$

$

$

$

1.0

Covid Related Expenses

$

$

0.2

$

$

$

0.8

Other (Income) Expense, net

$

(11.2)

$

(0.4)

$

(2.0)

$

(18.1)

$

(3.0)

Fair Value of Derivative Liabilities - Warrants

$

$

(0.4)

$

$

(0.3)

$

(2.6)

Results of Entities Not Legally Controlled

$

$

(0.9)

$

$

$

(1.9)

Adjusted EBITDA Non-GAAP

$

77.7

$

99.6

$

78.7

$

234.6

$

315.5

Reconciliation of Non-GAAP Adjusted Net Income (Loss)
The following table presents a reconciliation of GAAP net loss to non-GAAP adjusted net loss, for each of the periods presented:


For the Three Months Ended

For the Nine Months Ended

(Amounts expressed in millions of United
States dollars)

September 30,
2023

September 30,
2022

June 30,
2023

September 30,
2023

September 30,
2022

Net Loss GAAP

$

(25.4)

$

(114.6)

$

(403.8)

$

(493.4)

$

(169.0)

Add (Deduct) Impact of:











Impairment of Goodwill

$

$

$

307.6

$

307.6

$

Fair Value of Derivative Liabilities - Warrants

$

$

(0.4)

$

$

(0.3)

$

(2.6)

Inventory Step Up Fair Value

$

$

$

$

$

1.0

Transaction, Acquisition, and Integration Costs

$

8.5

$

15.5

$

5.7

$

16.1

$

45.9

Legislative Campaign Contributions

$

0.5

$

10.0

$

8.6

$

19.6

$

10.0

Covid Related Expenses

$

$

0.2

$

$

$

0.8

Impairments and Disposals of Long-lived
Assets, Net

$

(1.2)

$

54.6

$

3.3

$

5.5

$

76.2

Results of Discontinued Operations

$

2.9

$

42.4

$

63.9

$

97.9

$

53.2

Adjusted Net (Loss) Income Non-GAAP

$

(14.7)

$

7.9

$

(14.7)

$

(47.0)

$

15.4

Reconciliation of Non-GAAP Adjusted Earnings (Loss) Per Share
The following table presents a reconciliation of GAAP loss per share to non-GAAP adjusted earnings per share, for each of the periods presented:


For the Three Months Ended

For the Nine Months Ended

(Amounts expressed are per share)

September 30,
2023

September 30,
2022

June 30,
2023

September 30,
2023

September 30,
2022

Loss Per Share GAAP

$

(0.13)

$

(0.61)

$

(2.14)

$

(2.61)

$

(0.90)

Add (Deduct) Impact of:











Impairment of Goodwill

$

$

$

1.63

$

1.63

$

Fair Value of Derivative Liabilities - Warrants

$

$

0.00

$

$

0.00

$

(0.01)

Inventory Step Up Fair Value

$

$

$

$

$

0.01

Transaction, Acquisition, and Integration Costs

$

0.04

$

0.08

$

0.03

$

0.09

$

0.24

Legislative Campaign Contributions

$

0.00

$

0.05

$

0.05

$

0.10

$

0.05

Covid Related Expenses

$

$

0.00

$

$

$

0.00

Impairments and Disposals of Long-lived
Assets, Net

$

(0.01)

$

0.29

$

0.02

$

0.03

$

0.41

Results of Discontinued Operations

$

0.02

$

0.23

$

0.34

$

0.52

$

0.28

Adjusted Earnings Per Share Non-GAAP

$

(0.08)

$

0.04

$

(0.08)

$

(0.25)

$

0.08

Reconciliation of Non-GAAP Free Cash Flow
The following table presents a reconciliation of GAAP cash flow from operating activities to non-GAAP free cash flow, for each of the periods presented:


For the Three Months Ended

For the Nine Months Ended

(Amounts expressed in millions of United
States dollars)

September 30,
2023

September 30,
2022

June 30,
2023

September 30,
2023

September 30,
2022

Cash Flow From Operating Activities

$

93.4

$

(21.6)

$

(23.5)

$

70.4

$

(31.9)

Payments for Property and Equipment

$

(6.3)

$

(37.6)

$

(11.0)

$

(31.0)

$

(130.4)

Free Cash Flow

$

87.2

$

(59.2)

$

(34.5)

$

39.4

$

(162.3)

Forward-Looking Statements
This news release includes forward-looking information and statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to the Company's expectations or forecasts of business, operations, financial performance, prospects, and other plans, intentions, expectations, estimates, and beliefs and include statements regarding the Company's growth opportunities and the Company's positioning for the future. Words such as "expects", "continue", "will", "anticipates" and "intends" or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on the Company's current projections and expectations about future events and financial trends that management believes might affect its financial condition, results of operations, business strategy and financial needs, and on certain assumptions and analysis made by the Company in light of the experience and perception of historical trends, current conditions and expected future developments and other factors management believes are appropriate. Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements herein, including, without limitation, the risks discussed under the heading "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022 and in our periodic reports subsequently filed with the United Sates Securities and Exchange Commission and in the Company's filings on SEDAR at www.sedar.com . Although the Company believes that any forward-looking information and statements herein are reasonable, in light of the use of assumptions and the significant risks and uncertainties inherent in such information and statements, there can be no assurance that any such forward-looking information and statements will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements. Any forward-looking information and statements herein are made as of the date hereof and, except as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking information and statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward looking information and statements herein, whether as a result of new information, future events or results, or otherwise.

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with leading market positions in Arizona , Florida , and Pennsylvania . Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF . For more information, please visit Trulieve.com .

Facebook: @Trulieve
Instagram: @Trulieve_
Twitter: @Trulieve

Investor Contact
Christine Hersey , Vice President of Investor Relations
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

Media Contact
Phil Buck , APR, Corporate Communications Manager
+1 (406) 370-6226
Philip.Buck@Trulieve.com

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/trulieve-reports-third-quarter-2023-results-delivering-significant-cash-generation-301982628.html

SOURCE Trulieve Cannabis Corp.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2023/09/c6411.html

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×